Prescription drug · ANDA
Lacosamide NDC 70518-4503
Lacosamide 50 mg/1 · Tablet, Film coated · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4503-0 | 70518450300 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4503-0)Marketed from Oct 14, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lacosamide
- Generic name (nonproprietary)
- lacosamide
- Active ingredients
- Lacosamide — 50 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204974
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 70518-4503_5b862910-fd83-9666-e063-6294a90a2539SPL ID 5b862910-fd83-9666-e063-6294a90a2539
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518450300followed by a unit qualifier and the quantityPackage 70518-4503-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70518-4503
- What is NDC 70518-4503?
- 70518-4503 is the product NDC for Lacosamide, Lacosamide 50 mg/1 tablet, film coated, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lacosamide.
- What is the active ingredient?
- Lacosamide.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lacosamide?
- 144 other product NDCs are listed under this name. See all Lacosamide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lacosamide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4689 | 70518-4689-0070518-4689-0270518-4689-03 |
| Lacosamide | Lacosamide 10 mg/mL | Injection, SolutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | 68462-697 | 68462-0697-30 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4561 | 70518-4561-0070518-4561-02 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4562 | 70518-4562-00 |
| Lacosamide | Lacosamide 10 mg/mL | Injection, SolutionIntravenous | Anthea Pharma Private Limited | 83854-002 | 83854-0002-10 |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4504 | 70518-4504-0070518-4504-0170518-4504-03 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4505 | 70518-4505-00 |
| Lacosamide | Lacosamide 100 mg/10mL | SolutionOral | Precision Dose, Inc. | 68094-176 | 68094-0176-62 |
| Lacosamide | Lacosamide 50 mg/5mL | SolutionOral | Precision Dose, Inc. | 68094-076 | 68094-0076-62 |
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-008 | 85742-0008-0785742-0008-08 |
Other NDCs under ANDA 204974
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-171 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-172 |
| Lacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-173 |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-174 |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-174 |
| Lacosamide | Lacosamide 50 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-171 |
| Lacosamide | Lacosamide 200 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4504 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-172 |
| Lacosamide | Lacosamide 100 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4505 |
| Lacosamide | Lacosamide 150 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-173 |